Nasal Decongestant Final Rule Six-Month Stay Sought By P&G
This article was originally published in The Tan Sheet
Executive Summary
A six-month stay of the effective date of FDA's final rule switching the name of the OTC nasal decongestant ingredient l-desoxyephedrine to levmetamfetamine is requested by Procter & Gamble in a Sept. 7 petition.